Access the full text.
Sign up today, get DeepDyve free for 14 days.
P. Falk (1980)
The vascular pattern of the spontaneous C3H mouse mammary carcinoma and its significance in radiation response and in hyperthermia.European journal of cancer, 16 2
P. Okunieff, Friedrich Kallinowski, Peter Vaupel, L. Neuringer (1988)
Effects of hydralazine-induced vasodilation on the energy metabolism of murine tumors studied by in vivo 31P-nuclear magnetic resonance spectroscopy.Journal of the National Cancer Institute, 80 10
Charles Babbs, David DeWitt, W. Voorhees, Janet McCaw, Rosanna Chan (1982)
Theoretical feasibility of vasodilator-enhanced local tumor heating.European journal of cancer & clinical oncology, 18 11
(1962)
Changes of oxygen tension induced by vasoconstrictor and vasodilator drugs
R. Jain (1988)
Determinants of tumor blood flow: a review.Cancer research, 48 10
(1990)
The combined measurements of blood flow and metabolism in RIF-I tumours in vivo. A study using H2 flow and 31P NMR spectroscopy
(1987)
Manipulation of tumour oxygenation by hydralazine increases the potency of bioreductive radiosensitizers and enhances the effect of melphalan in experimental tumours
G. Tozer, C. Morris (1990)
Blood flow and blood volume in a transplanted rat fibrosarcoma: comparison with various normal tissues.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 17 2
P. Falk (1982)
Differences in vascular pattern between the spontaneous and the transplanted C3H mouse mammary carcinoma.European journal of cancer & clinical oncology, 18 2
H. Reinhold, B. Endrich (1986)
Tumour microcirculation as a target for hyperthermia.International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group, 2 2
(1967)
Blood flow and re-oxygenation of tumours in mice. Effects of vasodilators
J. Williams, J. Coggle, M. Charles, J. Wells (1986)
Skin carcinogenesis in the mouse following uniform and non-uniform beta irradiation.British journal of radiology. Supplement, 19
D. Chaplin, P. Olive, R. Durand (1987)
Intermittent blood flow in a murine tumor: radiobiological effects.Cancer research, 47 2
(1974)
Tumour angionesis factor
R. Thomlinson, L. Gray (1955)
The Histological Structure of Some Human Lung Cancers and the Possible Implications for RadiotherapyBritish Journal of Cancer, 9
(1987)
Potentiation of RSU-1069 tumour cytoxicity by hydralazine: a new approach to selective therapy
S. Hill, K. Smith, J. Denekamp (1989)
Reduced thermal sensitivity of the vasculature in a slowly growing tumour.International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group, 5 3
(1990)
The response of RIF-I tumours to the vasodilator hydralazine, assessed by 3'P-MRS, and measurements of blood flow and blood pressure
M. Horsman, Kent Christensen, Jens Overgaard (1989)
Hydralazine-induced enhancement of hyperthermic damage in a C3H mammary carcinoma in vivo.International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group, 5 2
I. Stratford, G. Adams, J. Godden, N. Howells (1989)
Induction of tumour hypoxia post-irradiation: a method for increasing the sensitizing efficiency of misonidazole and RSU 1069 in vivo.International journal of radiation biology, 55 3
J. McCredie, W. Inch, R. Sutherland (1971)
Differences in growth and morphology between the spontaneous C3H mammary carcinoma in the mouse and its syngeneic transplantsCancer, 27
(1987)
Exploitation of bioreductive agents with vasoactive drugs
R. Jain, K. Ward-Hartley (1984)
Tumor Blood Flow-Characterization, Modifications, and Role in HyperthermiaIEEE Transactions on Sonics and Ultrasonics, 31
The vast majority of studies on tumour vasculature are performed on transplanted tumours in rodents. However, it is known that there may be differences between primary and transplanted lesions. The purpose of this study is to test whether a specific vascular response is similar in primary tumours and in transplanted tumours derived from them. The technique used was to give an intraperitoneal injection of 5 mg kg-1 hydralazine, which is known to result in hypoxia in transplanted tumours. Changes in perfusion were indicated by changes in metabolism, monitored using 31P Magnetic Resonance Spectroscopy. The primary tumours were induced by local irradiation many months previously and only 4/11 (36%) of these responded to hydralazine. One of the non responders was subsequently transplanted into isogeneic mice to produce a tumour line which was histologically very similar to the primary. Of these 16/17 (94%) responded. The difference is statistically significant (P = 0.001). The reasons for this difference are not known. A number of possibilities are discussed and in the authors' opinion, the most likely cause is that it results from an artefact of transplantation.
British Journal of Cancer – Springer Journals
Published: May 1, 1991
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.